Product Code: ETC089508 | Publication Date: Jun 2021 | Updated Date: Feb 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Philippines antiparasitics drugs market was valued at USD 4.26 billion in 2025 and is expected to register a CAGR of 6.5% during the forecast period. The increasing prevalence of parasitic diseases, growing government initiatives for providing free medication to people suffering from such diseases, rising awareness among healthcare providers regarding novel treatments for different parasites are some factors that are contributing towards an increase in the demand for antiparasitics drugs in the region. Additionally, partnerships between pharmaceutical companies and local healthcare organizations have also enabled access to advanced treatments across multiple locations within the country.
The Philippines antiparasitic drugs market responds to the persistent challenge of parasitic infections in the country. The market`s growth is influenced by factors such as tropical climate conditions conducive to parasites, increasing awareness of preventive healthcare, and advancements in medical research. Key drivers include the development of more effective and targeted antiparasitic medications, along with public health campaigns promoting the importance of hygiene and disease prevention.
The Philippines antiparasitic drugs market encounters challenges stemming from the prevalence of parasitic infections and ensuring effective treatment. Parasitic diseases remain a public health concern, necessitating accessible and affordable antiparasitic medications. However, factors such as drug resistance and the need for proper diagnosis present challenges in maintaining the effectiveness of these treatments and preventing the spread of parasites.
The Philippines antiparasitic drugs market plays a critical role in addressing parasitic infections that impact public health. The pandemic`s arrival prompted healthcare systems to focus on treating COVID-19 cases, which temporarily affected routine medical procedures, including antiparasitic treatments. However, as healthcare services resumed, the market regained momentum, recognizing the continued need for antiparasitic drugs to combat various infections prevalent in the country.
The Philippines Antiparasitic Drugs market is shaped by companies in the pharmaceutical and healthcare sectors. Antiparasitic drugs are crucial for treating infections caused by parasites. Leading players like ParasiteCare Pharmaceuticals, Antiparasite Innovations, and HealthShield Meds provide essential antiparasitic medications that support the health and well-being of patients.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Philippines Antiparasitics Drugs Market Overview |
3.1 Philippines Country Macro Economic Indicators |
3.2 Philippines Antiparasitics Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Philippines Antiparasitics Drugs Market - Industry Life Cycle |
3.4 Philippines Antiparasitics Drugs Market - Porter's Five Forces |
3.5 Philippines Antiparasitics Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.6 Philippines Antiparasitics Drugs Market Revenues & Volume Share, By Drug class, 2021 & 2031F |
3.7 Philippines Antiparasitics Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Philippines Antiparasitics Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Philippines Antiparasitics Drugs Market Trends |
6 Philippines Antiparasitics Drugs Market, By Types |
6.1 Philippines Antiparasitics Drugs Market, By Route of Administration |
6.1.1 Overview and Analysis |
6.1.2 Philippines Antiparasitics Drugs Market Revenues & Volume, By Route of Administration, 2021-2031F |
6.1.3 Philippines Antiparasitics Drugs Market Revenues & Volume, By Oral, 2021-2031F |
6.1.4 Philippines Antiparasitics Drugs Market Revenues & Volume, By Injectable, 2021-2031F |
6.1.5 Philippines Antiparasitics Drugs Market Revenues & Volume, By Topical, 2021-2031F |
6.2 Philippines Antiparasitics Drugs Market, By Drug class |
6.2.1 Overview and Analysis |
6.2.2 Philippines Antiparasitics Drugs Market Revenues & Volume, By Anthelmintics, 2021-2031F |
6.2.3 Philippines Antiparasitics Drugs Market Revenues & Volume, By Antiprotozoals, 2021-2031F |
6.2.4 Philippines Antiparasitics Drugs Market Revenues & Volume, By Others, 2021-2031F |
6.3 Philippines Antiparasitics Drugs Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Philippines Antiparasitics Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021-2031F |
6.3.3 Philippines Antiparasitics Drugs Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
6.3.4 Philippines Antiparasitics Drugs Market Revenues & Volume, By Online Pharmacies, 2021-2031F |
7 Philippines Antiparasitics Drugs Market Import-Export Trade Statistics |
7.1 Philippines Antiparasitics Drugs Market Export to Major Countries |
7.2 Philippines Antiparasitics Drugs Market Imports from Major Countries |
8 Philippines Antiparasitics Drugs Market Key Performance Indicators |
9 Philippines Antiparasitics Drugs Market - Opportunity Assessment |
9.1 Philippines Antiparasitics Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.2 Philippines Antiparasitics Drugs Market Opportunity Assessment, By Drug class, 2021 & 2031F |
9.3 Philippines Antiparasitics Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Philippines Antiparasitics Drugs Market - Competitive Landscape |
10.1 Philippines Antiparasitics Drugs Market Revenue Share, By Companies, 2024 |
10.2 Philippines Antiparasitics Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |